Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A Meeting Abstract


Authors: Mazieres, J.; Paik, P. K.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Viteri, S.; Garassino, M. C.; Van Meerbeeck, J. P.; Raskin, J.; Thomas, M.; Morise, M.; Cho, B. C.; Conte, P.; Bruns, R.; Demuth, T.; Schumacher, K. M.; Le, X.
Abstract Title: Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S828
End Page: S829
Language: English
ACCESSION: WOS:000573469101569
DOI: 10.1016/j.annonc.2020.08.1597
PROVIDER: wos
Notes: Meeting Abstract: 1283P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik